{{Drugbox
| IUPAC_name = (3''E'')-4-(4-methoxyphenyl)-1-morpholin-4-ylbut-3-en-2-ol
| image = Metostilenol.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number = 103980-45-6
| ATC_prefix = None
| ATC_suffix =  
| PubChem = 6446648
| ChemSpiderID = 4950173
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 737T1YVX89

<!--Chemical data-->
| C=15 | H=21 | N=1 | O=3 
| molecular_weight = 263.33 g/mol
| smiles = OC(\C=C\c1ccc(OC)cc1)CN2CCOCC2
}}

'''Metostilenol''' is a [[drug]] which was patented as an [[antidepressant]] in the early 1980s, but was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=A0THacd46ZsC&lpg=PA1346&dq=metostilenol&pg=PA1346#v=onepage&q=metostilenol&f=false}}</ref>

== References ==
{{Reflist}}

{{Antidepressants}}

[[Category:Alcohols]]
[[Category:Antidepressants]]
[[Category:Morpholines]]
[[Category:Abandoned drugs]]

{{nervous-system-drug-stub}}